NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance

• Main Authors: Monisha J., Roy N.K., Padmavathi G., Banik K., Bordoloi D., Khwairakpam A.D., Arfuso F., Chinnathambi A., Alahmadi T.A., Alharbi S.A., Sethi G., Kumar A.P., Kunnumakkara A.B.
• Other Authors: DEPT OF PHARMACOLOGY
• Format: Article
• Published: MDPI AG 2019
• Subjects: Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/152462
• Institution: National University of Singapore

10.3390/cancers10070228